Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syndrome Differentiation vs Fixed Formula for Perimenopausal Syndrome
NCT05266079Completed
- Sponsor
- Hong Kong Baptist University
- Start
- Mar 2022
- Primary completion
- Jun 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of Gan Mai Bai He Di Huang Tang, tian wang bu xin dan, shugan granules, liuwei dihuang wan, erzhi pill and 2 more in climacteric, sponsored by Hong Kong Baptist University. Started Mar 2022; status: completed.
02
Drugs
Gan Mai Bai He Di Huang Tangtian wang bu xin danshugan granulesliuwei dihuang wanerzhi pill
03
Conditions
climacteric
Beyond the preview
Go deeper on NCT05266079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266079.